Ischemia-reperfusion injury in transplantation: novel mechanisms and protective strategies

Transplantation Reviews

Volumn 21, Issue 1, 2007, Pages 43-53

  Foley, David P ^a   Chari, Ravi S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIVERDIN; CALCIUM ION; CARBON MONOXIDE; CASPASE 3; CASPASE 8; CHIMERIC PROTEIN; CURCUMIN; FAS ANTIGEN; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPASE C; PHOSPHOLIPASE C DELTA1; RIBOZYME; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ALLOGRAFT; ALLOTRANSPLANTATION; ARTICLE; CADAVER DONOR; CALCIUM SIGNALING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GRAFT SURVIVAL; HUMAN; INNATE IMMUNITY; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; REPERFUSION INJURY; RISK REDUCTION; SURGICAL RISK; TREATMENT INDICATION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

EID: 34147093638     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2007.01.004     Document Type: Article

References (135)

1. Muiesan P., Jassem W., Girlanda R., Steinberg R., Vilca-Melendez H., Mieli-Vergani G., et al. Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future. Am J Transplant 6 (2006) 1012-1016
2. Foley D.P., Fernandez L.A., Leverson G., Chin L.T., Krieger N., Cooper J.T., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242 (2005) 724-731
3. Humar A., Ramcharan T., Kandaswamy R., Gruessner R.W., Gruessner A.G., and Sutherland D.E. The impact of donor obesity on outcomes after cadaver pancreas transplants. Am J Transplant 4 (2004) 605-610
4. Tector A.J., Mangus R.S., Chestovich P., Vianna R., Fridell J.A., Milgrom M.L., et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 244 (2006) 439-450
5. Moreso F., Seron D., Gil-Vernet S., Riera L., Fulladosa X., Ramos R., et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 14 (1999) 930-935
6. Vianello A., Mastrosimone S., Calconi G., Da Porto A., Palminteri G., D'annibale A., et al. Influence of donor age on cadaver kidney graft function and survival: univariate and multivariate analyses. Nephron 65 (1993) 541-548
7. Hoofnagle J.H., Lombardero M., Zetterman R.K., Lake J., Porayko M., Everhart J., et al. Donor age and outcome of liver transplantation. Hepatology 24 (1996) 89-96
8. Tan M., Kandaswamy R., Sutherland D.E., Gruessner R.W., Gruessner A.C., and Humar A. Risk factors and impact of delayed graft function after pancreas transplants. Am J Transplant 4 (2004) 758-762
9. Moore D.E., Feurer I.D., Speroff T., Gorden D.L., Wright J.K., Chari R.S., et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140 (2005) 273-277
10. Khapra A.P., Agarwal K., Fiel M.I., Kontorinis N., Hossain S., Emre S., et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 12 (2006) 1496-1503
11. Berenguer M., Prieto M., San Juan F., Rayon J.M., Martinez F., Carrasco D., et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36 (2002) 202-210
12. Ploeg R.J., D'alessandro A.M., Knechtle S.J., Stegall M.D., Pirsch J.D., Hoffmann R.M., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807-813
13. Humar A., Kandaswamy R., Drangstveit M.B., Parr E., Gruessner A.G., and Sutherland D.E. Prolonged preservation increases surgical complications after pancreas transplants. Surgery 127 (2000) 545-551
14. Cooper J.T., Chin L.T., Krieger N.R., Fernandez L.A., Foley D.P., Becker Y.T., et al. Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 4 (2004) 1490-1494
15. Weber M., Dindo D., Demartines N., Ambuhl P.M., and Clavien P.A. Kidney transplantation from donors without a heartbeat. N Engl J Med 347 (2002) 248-255
16. Glanemann M., Langrehr J.M., Stange B.J., Neumann U., Settmacher U., Steinmuller T., et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 3 (2003) 1003-1009
17. Mueller A.R., Platz K.P., Haak M., Undi H., Muller C., Kottgen E., et al. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 62 (1996) 1118-1126
18. Halloran P.F. Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2 (2002) 195-200
19. Gourishankar S., and Halloran P.F. Late deterioration of organ transplants: a problem in injury and homeostasis. Curr Opin Immunol 14 (2002) 576-583
20. Lemasters J.J., and Thurman R.G. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 37 (1997) 327-338
21. Arumugam T.V., Magnus T., Woodruff T.M., Proctor L.M., Shiels I.A., and Taylor S.M. Complement mediators in ischemia-reperfusion injury. Clin Chim Acta 374 (2006) 33-45
22. Zhai Y., Shen X.D., Hancock W.W., Gao F., Qiao B., Lassman C., et al. CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J Immunol 176 (2006) 6313-6322
23. Gasser M., Waaga A.M., Kist-Van Holthe J.E., Lenhard S.M., Laskowski I., Shaw G.D., et al. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol 13 (2002) 1937-1945
24. Takada M., Nadeau K.C., Hancock W.W., Mackenzie H.S., Shaw G.D., Waaga A.M., et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 65 (1998) 1533-1542
25. Kosieradzki M., Kuczynska J., Piwowarska J., Wegrowicz-Rebandel I., Kwiatkowski A., Lisik W., et al. Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 75 (2003) 1221-1227
26. Clavien P.A., Harvey P.R., and Strasberg S.M. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53 (1992) 957-978
27. Ikeda T., Yanaga K., Kishikawa K., Kakizoe S., Shimada M., and Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16 (1992) 454-461
28. Mckeown C.M., Edwards V., Phillips M.J., Harvey P.R., Petrunka C.N., and Strasberg S.M. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 46 (1988) 178-191
29. Upadhya A.G., Harvey R.P., Howard T.K., Lowell J.A., Shenoy S., and Strasberg S.M. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology 26 (1997) 922-928
30. Gao W., Bentley R.C., Madden J.F., and Clavien P.A. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 27 (1998) 1652-1660
31. Khandoga A., Hanschen M., Kessler J.S., and Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43 (2006) 306-315
32. Anderson C.D., Belous A., Pierce J., Nicoud I.B., Knox C., Wakata A., et al. Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis. Am J Transplant 4 (2004) 352-362
33. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
34. Johnson G.B., Brunn G.J., Tang A.H., and Platt J.L. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 24 (2003) 19-24
35. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303 (2004) 1522-1526
36. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
37. Tsung A., Hoffman R.A., Izuishi K., Critchlow N.D., Nakao A., Chan M.H., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175 (2005) 7661-7668
38. Zhai Y., Shen X.D., O'connell R., Gao F., Lassman C., Busuttil R.W., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004) 7115-7119
39. Kopp E., and Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15 (2003) 396-401
40. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79 (2005) 505-514
41. Johnson G.B., Brunn G.J., Kodaira Y., and Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168 (2002) 5233-5239
42. Tesar B.M., Jiang D., Liang J., Palmer S.M., Noble P.W., and Goldstein D.R. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 6 (2006) 2622-2635
43. Smiley S.T., King J.A., and Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167 (2001) 2887-2894
44. Hollestelle S.C., De Vries M.R., Van Keulen J.K., Schoneveld A.H., Vink A., Strijder C.F., et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109 (2004) 393-398
45. Stapel H., Kim S.C., Osterkamp S., Knuefermann P., Hoeft A., Meyer R., et al. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur J Heart Fail 8 (2006) 665-672
46. Oyama J., Blais Jr. C., Liu X., Pu M., Kobzik L., Kelly R.A., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004) 784-789
47. Tsoulfas G., Takahashi Y., Ganster R.W., Yagnik G., Guo Z., Fung J.J., et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 74 (2002) 7-13
48. Goldstein D.R., Tesar B.M., Akira S., and Lakkis F.G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111 (2003) 1571-1578
49. Shen X.D., Ke B., Zhai Y., Gao F., Busuttil R.W., Cheng G., et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 5 (2005) 1793-1800
50. Yotov W.V., and St-Arnaud R. Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1). Nucleic Acids Res 20 (1992) 3516
51. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
52. Izuishi K., Tsung A., Jeyabalan G., Critchlow N.D., Li J., Tracey K.J., et al. Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 176 (2006) 7154-7158
53. Boros P., and Bromberg J.S. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6 (2006) 652-658
54. Applegate L.A., Luscher P., and Tyrrell R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 51 (1991) 974-978
55. Choi A.M., and Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15 (1996) 9-19
56. Katori M., Busuttil R.W., and Kupiec-Weglinski J.W. Heme oxygenase-1 system in organ transplantation. Transplantation 74 (2002) 905-912
57. Coito A.J., Buelow R., Shen X.D., Amersi F., Moore C., Volk H.D., et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74 (2002) 96-102
58. Amersi F., Buelow R., Kato H., Ke B., Coito A.J., Shen X.D., et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104 (1999) 1631-1639
59. Kato H., Amersi F., Buelow R., Melinek J., Coito A.J., Ke B., et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 1 (2001) 121-128
60. Katori M., Buelow R., Ke B., Ma J., Coito A.J., Iyer S., et al. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73 (2002) 287-292
61. Blydt-Hansen T.D., Katori M., Lassman C., Ke B., Coito A.J., Iyer S., et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 14 (2003) 745-754
62. Pileggi A., Molano R.D., Berney T., Cattan P., Vizzardelli C., Oliver R., et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50 (2001) 1983-1991
63. Kotsch K., Francuski M., Pascher A., Klemz R., Seifert M., Mittler J., et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 6 (2006) 477-486
64. Mcnally S.J., Harrison E.M., Ross J.A., Garden O.J., and Wigmore S.J. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19 (2007) 165-172
65. Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., and Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 131 (2001) 2090-2095
66. Katori M., Anselmo D.M., Busuttil R.W., and Kupiec-Weglinski J.W. A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system. Transpl Immunol 9 (2002) 227-233
67. Nakao A., Choi A.M., and Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 10 (2006) 650-671
68. Agarwal A., Kim Y., Matas A.J., Alam J., and Nath K.A. Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation 61 (1996) 93-98
69. Stocker R., Yamamoto Y., Mcdonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
70. Fondevila C., Shen X.D., Tsuchiyashi S., Yamashita K., Csizmadia E., Lassman C., et al. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40 (2004) 1333-1341
71. Adin C.A., Croker B.P., and Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288 (2005) F778-F784
72. Kirkby K.A., Baylis C., Agarwal A., Croker B.P., Archer L., and Adin C.A. Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol Renal Physiol 7 (2006) 888-894
73. Nakao A., Neto J.S., Kanno S., Stolz D.B., Kimizuka K., Liu F., et al. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5 (2005) 282-291
74. Nakao A., Toyokawa H., Tsung A., Nalesnik M.A., Stolz D.B., Kohmoto J., et al. Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 6 (2006) 2243-2255
75. Minamoto K., Harada H., Lama V.N., Fedarau M.A., and Pinsky D.J. Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J Exp Med 202 (2005) 283-294
76. Martins P.N., Reutzel-Selke A., Jurisch A., Denecke C., Attrot K., Pascher A., et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 82 (2006) 938-944
77. Petrache I., Otterbein L.E., Alam J., Wiegand G.W., and Choi A.M. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 278 (2000) L312-L319
78. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 (2000) 1015-1026
79. Sato K., Balla J., Otterbein L., Smith R.N., Brouard S., Lin Y., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166 (2001) 4185-4194
80. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., and Wysk M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 (2000) 422-428
81. Silverman H.S., and Stern M.D. Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc Res 28 (1994) 581-597
82. Miyata H., Lakatta E.G., Stern M.D., and Silverman H.S. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 71 (1992) 605-613
83. Lattanzio Jr. F.A. The effects of pH and temperature on fluorescent calcium indicators as determined with Chelex-100 and EDTA buffer systems. Biochem Biophys Res Commun 171 (1990) 102-108
84. Snowdowne K.W., Freudenrich C.C., and Borle A.B. The effects of anoxia on cytosolic free calcium, calcium fluxes, and cellular ATP levels in cultured kidney cells. J Biol Chem 260 (1985) 11619-11626
85. Blankensteijn J.D., and Terpstra O.T. Liver preservation: the past and the future. Hepatology 13 (1991) 1235-1250
86. Kim J.S., and Southard J.H. Alteration in cellular calcium and mitochondrial functions in the rat liver during cold preservation. Transplantation 65 (1998) 369-375
87. Mccord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
88. Madesh M., and Hajnoczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155 (2001) 1003-1015
89. Mcconkey D.J., and Orrenius S. The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239 (1997) 357-366
90. Ylitalo K.V., Ala-Rami A., Liimatta E.V., Peuhkurinen K.J., and Hassinen I.E. Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning. J Mol Cell Cardiol 32 (2000) 1223-1238
91. Hunter D.R., and Haworth R.A. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195 (1979) 453-459
92. Hunter D.R., and Haworth R.A. The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys 195 (1979) 468-477
93. Knox C.D., Belous A.E., Pierce J.M., Wakata A., Nicoud I.B., Anderson C.D., et al. Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptake. Am J Physiol Gastrointest Liver Physiol 287 (2004) G533-G540
94. Chen Q., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 319 (2006) 1405-1412
95. Li Y.X., Li G., Dong W.P., Lu D.R., and Tan J.M. Protection of human islets from induction of apoptosis and improved islet function with HO-1 gene transduction. Chin Med J (Engl) 119 (2006) 1639-1645
96. Li Y., Li G., Dong W., Chen J., Lu D., and Tan J. Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector. Pancreas 33 (2006) 280-286
97. Ke B., Shen X.D., Lassman C.R., Gao F., Katori M., Busuttil R.W., et al. Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion. Transplantation 75 (2003) 1118-1123
98. Ke B., Lipshutz G.S., and Kupiec-Weglinski J.W. Gene therapy in liver ischemia and reperfusion injury. Curr Pharm Des 12 (2006) 2969-2975
99. Sonnenday C.J., Warren D.S., Cooke S.K., Dietz H.C., and Montgomery R.A. A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium. J Gene Med 6 (2004) 1394-1402
100. Land W.G. Immunosuppressive strategies in organ transplantation in the light of innate immunity. Exp Clin Transplant 4 (2006) 406-415
101. Zheng X., Zhang X., Sun H., Feng B., Li M., Chen G., et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82 (2006) 1781-1786
102. Contreras J.L., Vilatoba M., Eckstein C., Bilbao G., Anthony Thompson J., and Eckhoff D.E. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. Surgery 136 (2004) 390-400
103. Du C., Wang S., Diao H., Guan Q., Zhong R., and Jevnikar A.M. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am J Transplant 6 (2006) 2256-2267
104. Bantounas I., Phylactou L.A., and Uney J.B. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol 33 (2004) 545-557
105. Murry C.E., Jenningsx C.E., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
106. Sindram D., Rudiger H.A., Upadhya A.G., Strasberg S.M., and Clavien P.A. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol 36 (2002) 78-84
107. Yin D.P., Sankary H.N., Chong A.S., Ma L.L., Shen J., Foster P., et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 66 (1998) 152-157
108. Sola A., De Oca J., Gonzalez R., Prats N., Rosello-Catafau J., Gelpi E., et al. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 234 (2001) 98-106
109. Ferencz A., Szanto Z., Borsiczky B., Kiss K., Kalmar-Nagy K., Szeberenyi J., et al. The effects of preconditioning on the oxidative stress in small-bowel autotransplantation. Surgery 132 (2002) 877-884
110. Torras J., Herrero-Fresneda I., Lloberas N., Riera M., Ma Cruzado J., and Ma Grinyo J. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 61 (2002) 2218-2227
111. Fuller T.F., Freise C.E., Feng S., and Niemann C.U. Ischemic preconditioning improves rat kidney graft function after severe ischemia/reperfusion injury. Transplant Proc 37 (2005) 377-378
112. Landymore R.W., Bayes A.J., Murphy J.T., and Fris J.H. Preconditioning prevents myocardial stunning after cardiac transplantation. Ann Thorac Surg 66 (1998) 1953-1957
113. Li G., Chen S., Lou W., and Lu E. Protective effects of ischemic preconditioning on donor lung in canine lung transplantation. Chest 113 (1998) 1356-1359
114. Arai M., Thurman R.G., and Lemasters J.J. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 7 (2001) 292-299
115. Fernandez L., Carrasco-Chaumel E., Serafin A., Xaus C., Grande L., Rimola A., et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation?. Am J Transplant (2004) F888-F899
116. Selzner N., Selzner M., Jochum W., and Clavien P.A. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol 39 (2003) 55-61
117. Niemann C.U., Hirose R., Liu T., Behrends M., Brown J.L., Kominsky D.F., et al. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg 101 (2005) 1577-1583
118. Drognitz O., Liu X., Obermaier R., Neeff H., Von Dobschuetz E., Hopt U.T., et al. Ischemic preconditioning fails to improve microcirculation but increases apoptotic cell death in experimental pancreas transplantation. Transpl Int 17 (2004) 317-324
119. Clavien P.A., Selzner M., Rudiger H.A., Graf R., Kadry Z., Rousson V., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238 (2003) 843-850 [discussion 851-852]
120. Nuzzo G., Giuliante F., Vellone M., De Cosmo G., Ardito F., Murazio M., et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 10 (2004) S53-S57
121. Azoulay D., Del Gaudio M., Andreani P., Ichai P., Sebag M., Adam R., et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 242 (2005) 133-139
122. Koneru B., Fisher A., He Y., Klein K.M., Skurnick J., Wilson D.J., et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 11 (2005) 196-202
123. Jassem W., Fuggle S.V., Cerundolo L., Heaton N.D., and Rela M. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 81 (2006) 169-174
124. Cescon M., Grazi G.L., Grassi A., Ravaioli M., Vetrone G., Ercolani G., et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 12 (2006) 628-635
125. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
126. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85
127. Gho B.C., Schoemaker R.G., Van Den Doel M.A., Duncker D.J., and Verdouw P.D. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 94 (1996) 2193-2200
128. Li G., Labruto F., Sirsjo A., Chen F., Vaage J., and Valen G. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase. Eur J Cardiothorac Surg 26 (2004) 968-973
129. Li C.M., Zhang X.H., Ma X.J., and Luo M. Limb ischemic postconditioning protects myocardium from ischemia-reperfusion injury. Scand Cardiovasc J 40 (2006) 312-317
130. Kerendi F., Kin H., Halkos M.E., Jiang R., Zatta A.J., Zhao Z.Q., et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 100 (2005) 404-412
131. Zhu M., Feng J., Lucchinetti E., Fischer G., Xu L., Pedrazzini T., et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 72 (2006) 152-162
132. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15 (2005) 69-75
133. Yue T.L., Wang C., Gu J.L., Ma X.L., Kumar S., Lee J.C., et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86 (2000) 692-699
134. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65 (2005) 361-367
135. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'huillier I., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148